- The launch of Rivastigmine Transdermal System highlights Mylan's continued investment in difficult-to-manufacture products -
PR Newswire
HERTFORDSHIRE, England and PITTSBURGH, July 9, 2018
PR Newswire
HERTFORDSHIRE, England and PITTSBURGH, July 9, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey